Martin Borch Jensen

Martin Borch Jensen has extensive work experience in the field of aging research.

Martin co-founded Gordian Biotechnology in 2018 and holds the position of co-founder and CSO.

In 2022, they joined The Alliance for Longevity Initiatives as a member of the Scientific Advisory Board.

Since 2021, they have been serving as the President of Norn Group, a non-profit organization focused on accelerating research and development of therapies targeting the biology of aging.

Prior to that, Martin worked at the Buck Institute for Research on Aging from 2013 to 2018. Martin started as a Postdoc/K99 Fellow in the Jasper lab, where they studied mitochondrial proteostatic stress and its impact on cellular states and lifespan. Martin then received the NIH K99/R00 Pathway to Independence award to study the role of intestinal bacteria in neurodegenerative disease. However, they returned this funding after one year to start Gordian Biotechnology.

In 2013, Martin worked as an author and completed mandatory military service in the Royal Danish Air Force. Martin co-authored a book on intermittent fasting and shared their knowledge on the topic through appearances in national newspapers, television, and radio.

Martin's career in aging research began in 2010 when they worked as a Ph.D. student in the Bohr lab at the National Institute on Aging & University of Copenhagen - Center for Healthy Aging. Martin'sresearch focused on DNA repair and its role in the aging process, with a particular emphasis on accelerated aging disorders. Martin received the EliteForsk scholarship, the most prestigious scholarship in Denmark, and published multiple papers during this time.

Martin Borch Jensen's education history begins in 2001 when they attended Nørre Gymnasium International Baccalaureate, where they pursued their high school education. In 2004, they moved on to Københavns Universitet - University of Copenhagen, where they earned a Bachelor's and Master's degree in Nanotechnology, completing their studies in 2009. Martin's academic journey continued at the National Institute on Aging / University of Copenhagen, where they obtained their Ph.D. in Biogerontology, finishing in 2013.